Drreddys Laboratories reported INR17.46B in EBIT for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Ani Pharmaceuticals ANIP:US USD 3.39M 6.84M
Aurora Cannabis Inc ACB:CN CAD -74868000 1.84M
Bayer BAYN:GR EUR 3.94B 2.59B
Canopy Growth Corp WEED:CN CAD -118158000 885K
Catalent CTLT:US USD 139M 81M
Cipla CIPLA:IN INR 11.35B 1.32B
Corcept Therapeutics CORT:US USD 22.5M 9.43M
Drreddys Laboratories RDY:US INR 17.46B 1.31B
Endo International Ordinary Shares ENDP:US USD 55.64M 26.07M
GlaxoSmithKline GSK:LN GBP 1.44B 967M
Hikma Pharmaceutical HIK:LN USD 302M 46M
Horizon Pharma HZNP:US USD 214.96M 26.8M
JAZZ PHA JAZZ:US USD -263386000 462.6M
Lonza Group LONN:SW CHF 699M 1000K
Novartis NOVN:VX USD 3.1B 228M
Pacira Pharmaceuticals PCRX:US USD 14.24M 7.54M
Phibro Animal Health PAHC:US USD 22.41M 8.73M
Prestige Brands PBH:US USD 87.18M 2.8M
Richter Gedeon RICHT:HB HUF 64.49B 21.04B
Sun Pharmaceuticals SUNP:IN INR 23.47B 2.41B
Supernus Pharmaceuticals SUPN:US USD 34.33M 35.86M
Teva Pharmaceutical TEVA:IT USD 999M 259M